Top 5 US Stocks To Buy In March 2025

These 5 stocks are our top Pro Picks for this month, taken from S&P 500-listed companies that have garnered high InvestingPro health ratings (benchmarked against more than 100 financial factors and indicators from companies in the same sector), as well as from among those trading well under our proprietary fair value estimates (based on 5 overlaid investing models) and analyst assessments.

All of these names have earned InvestingPro health scores of well above 3.00, which for the last 7 years has indicated outperformance vs. the S&P 500. A score this high points to a mix of first-rate financials: excellent earnings, cash flow, and growth vs. peers in its sector.

Importantly, all of these stocks are also currently undervalued per InvestingPro’s fair value calculations and favored by Wall Street analysts polled by InvestingPro. They’re also sitting with a current potential upside of more than 20%. So if you’re eager to bulk up your portfolio, these overlooked powerhouse plays are all worth serious consideration.

• InvestingPro health score: 3.66 / 5.00
• InvestingPro average fair value: $51.71 / 51.3% upside
• Fair value confidence: High
• Industry: Healthcare / Pharmaceuticals

Harmony Biosciences Holdings, Inc. (HRMY) stands out as a compelling investment opportunity in the biopharmaceutical sector for March 2025. Specializing in innovative therapies for rare neurological disorders, Harmony has made significant strides, backed by a robust development pipeline and promising product lineup. As of the end of February 2025, Harmony Biosciences has a market capitalization of approximately $1.94 billion, demonstrating its robust position as a mid-cap firm in the competitive biotech domain.

The company currently does not pay a dividend, choosing instead to allocate its profits towards research and development efforts aimed at expanding its market offerings and driving sustained growth. Harmony’s P/E ratio is reported at 15.9, which is above industry norms in relation to its closest peers, but still holds potential for upside (analysts anticipate roughly a 51.3% potential upside) due to anticipated product launches and expanding market reach.

Harmony maintains a prudent approach to debt management, providing the flexibility needed to support its strategic expansions, including partnerships and potential new acquisitions in the sector. Investors should note that while the biotech industry can be volatile, Harmony’s focus on unique therapeutic areas provides it with a defensive edge.

Overall, Harmony Biosciences offers a promising opportunity for investors seeking exposure to the biotech field, particularly those interested in companies with strong growth trajectories and strategic initiatives aimed at addressing unmet medical needs.

• InvestingPro health score: 3.57 / 5.00
• InvestingPro average fair value: $58.54 / 29.3% upside
• Fair value confidence: Medium
• Industry: Energy / Oil, Gas & Consumable Fuels

International Seaways (INSW) returns again as a stock pick for March 2025. As of the latest quarter, the company boasts a market capitalization of around $1.84 billion, marking it as a notable player in the energy transportation industry. International Seaways specializes in transporting crude oil and petroleum products, leveraging a diversified and modern fleet to capitalize on global energy demand.

The company pays a quarterly dividend of (currently) 15.4%, providing investors with steady income alongside potential capital appreciation. With a P/E ratio of 3.6, International Seaways appears relatively undervalued compared to industry peers, hinting at potential upside, especially if energy markets remain robust.

International Seaways maintains a prudent debt strategy, evidenced by a debt-to-equity ratio of 35.5%, which supports its operational flexibility and expansion initiatives. Investors considering this stock should be aware of the inherent volatility associated with shipping rates and global economic shifts, which can impact performance.

Despite these fluctuations, International Seaways’ strategic positioning and disciplined financial management enhance its appeal. The company is well-positioned to benefit from favorable market conditions, making it a compelling choice for investors seeking exposure to a dynamic sector with the potential for both income and growth.

• InvestingPro health score: 3.01 / 5.00
• InvestingPro average fair value: $1,954.54 / 20.0% upside
• Fair value confidence: Medium
• Industry: Financials / Insurance

White Mountains Insurance Group (WTM) presents a solid investment opportunity as we head into March 2025, especially for investors seeking stability in the financial sector. With a market capitalization of roughly $4.60 billion as of the end of February, White Mountains is a significant player in the insurance industry. Notably, the company has focused on strategic investment and acquisition activities that bolster its diversified portfolio within insurance and related industries.

While White Mountains’ dividend is only 0.1%, it has nevertheless been consistent with its payments for more than 30 years, and this also shows the business instead prioritizes strategic growth, reinvesting earnings to enhance shareholder value through a range of acquisitions and ventures. This approach is underscored by the company’s P/E ratio of 20.0, suggesting it may be undervalued compared to its peers in the insurance sector, potentially providing an attractive upside for investors who believe in its long-term strategy.

Debt is well-managed, with White Mountains maintaining a prudent balance sheet that supports its investment endeavors without compromising financial stability. Potential investors should take into account that while the insurance sector can provide consistent returns, White Mountains’ focus on acquisitions means there can be inherent volatility related to these business changes.

Overall, White Mountains Insurance Group offers a compelling opportunity for investors looking to diversify their portfolios with a stable yet strategically progressive company in the insurance sector.

• InvestingPro health score: 3.24 / 5.00
• InvestingPro average fair value: $117.63 / 42.3% upside
• Fair value confidence: High
• Industry: Marine Transportation

Danaos Corp (DAC) stands out as a noteworthy stock pick for March 2025, particularly for investors interested in the maritime shipping sector. As of the close of February, Danaos boasts a market capitalization of approximately $1.59 billion, positioning it as a significant player in the container shipping industry. The company has earned recognition for its expansive fleet and strategic partnerships, allowing it to capitalize on global trade dynamics.

Danaos offers an attractive dividend yield, currently at 4.1%, providing an added incentive for income-focused investors. The company maintains a P/E ratio of 3.2, suggesting that the stock is undervalued relative to its earnings, offering a promising upside of more than 42.3% for those looking to capitalize on market inefficiencies.

In terms of financial health, Danaos manages its debt prudently, with a focus on refinancing its liabilities to maintain operational flexibility and fund future growth. Investors should be conscious, however, of the inherent volatility in the shipping industry, driven by fluctuating freight rates and global economic conditions.

Overall, Danaos Corp presents a compelling investment opportunity, combining a strong dividend with growth potential in the dynamic shipping industry. Its ability to adapt to market changes and its strategic positioning in the global trade sector underscore its appeal to investors seeking both stability and growth prospects.

• InvestingPro health score: 3.23 / 5.00
• InvestingPro average fair value: $61.36 / 53.2% upside
• Fair value confidence: Medium
• Industry: Consumer Discretionary / Broadline Retail

JD.com (JD) is an exciting prospect for investors eyeing the e-commerce and tech sectors, especially during this dynamic market period. As of the latest data, JD.com sports a formidable market capitalization of approximately $56.98 billion, underlining its status as a major player in the global online retail space. Known for its commitment to technological integration and robust logistics network, JD.com stands out in the competitive landscape.

The company’s Price-to-Earnings (P/E) ratio currently hovers around 11.8, reflecting market expectations for continued growth. JD.com currently distributes dividends at a yield of 1.9%, strategically channeling the rest of its resources into expanding its infrastructure and enhancing technological capabilities, prioritizing long-term shareholder value through capital appreciation.

Financially, JD.com maintains a strong balance sheet, with a prudent approach to debt, which provides it with resilience and flexibility to navigate market fluctuations. This disciplined financial strategy is crucial, given the inherent volatility of the tech sector, particularly in the face of geopolitical nuances and consumer behavior shifts in China.

For investors seeking potential upside, JD.com’s focus on innovation and its expanding presence in diverse markets such as cloud computing and AI-driven retail solutions offer compelling growth prospects. However, they should exercise caution regarding volatility, driven by broader economic conditions and regulatory developments.

Overall, JD.com provides a promising investment avenue for those looking to capitalize on e-commerce growth within a robust and adaptable company framework.

If you’re looking for more great opportunities, here is a list of our top stock picks for previous 12 months.